Cellular Immunotherapy Market

Cellular Immunotherapy Market Size, Share, Growth Analysis, By Therapy Type(CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy), By Indication(B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carcinoma), By End-use(Hospitals, Cancer Institutes, Others), By Region(North America, Europe, Asia Pacific, Latin America) - Industry Forecast 2024-2031


Report ID: UCMIG35E2027 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Cellular Immunotherapy Market Insights

Market Overview:

In 2021, the worldwide market for cellular immunotherapy reached a significant valuation of USD 6.13 billion. The future outlook appears promising as it is expected to experience a robust compound annual growth rate (CAGR) of 22.41% from 2022 until 2030. This growth projection reflects the escalating demand and increasing adoption of cellular immunotherapy as an effective treatment approach. With its potential to revolutionize the field of Health Care, cellular immunotherapy is poised to make substantial contributions in addressing various diseases and medical conditions, driving its market expansion in the coming years.

Cellular Immunotherapy Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Facilities by segment aggregation, the contribution of the Health Care Facilities in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Cellular Immunotherapy was estimated to be valued at US$ XX Mn in 2021.

The Cellular Immunotherapy Market is estimated to grow at a CAGR of XX% by 2028.

The Cellular Immunotherapy Market is segmented on the basis of Therapy Type, Indication, End-use, Region.

Based on region, the Cellular Immunotherapy Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Cellular Immunotherapy Market are , Bristol-Myers Squibb Company , Novartis AG , Gilead Sciences Inc. (Kite Pharma) , F. Hoffmann-La Roche Ltd , Merck KGaA , GlaxoSmithKline plc. , AstraZeneca , Pfizer Inc. , Johnson & Johnson , Celyad, Adicet Bio, Inc. , Dendreon Pharmaceuticals LLC .

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Cellular Immunotherapy Market

Report ID: UCMIG35E2027

$5,300
BUY NOW GET FREE SAMPLE